KHAN NAJAT (CEO and President) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/19/2026ACC: 0002020969-26-000002
DirectorOfficer· CEO and President
Since Feb 2026
-62.70K
Net shares
Net seller
$190.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
62.70K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−62.70K
Price / share
$3.04
Trade value
$190.61K
% of position
2.8%
5/15/2026
2.26M→2.20M
Total
Net shares
−62.70K
Net value
-$190.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/15/2026 | F · Tax Withholding | −62.70K | $3.04 | $190.61K | 2.8% | 2.26M | 2.20M |
| Total | −62.70K | -$190.61K | ||||||
Derivative Transactions0
No derivative transactions reported